Ruth Franken

Ruth Franken

Senior Associate

Email ruth.franken@​

Phone +31 20 55 33 738

Fax +31 20 55 33 777

LanguagesEnglish, Dutch

Practice groupGlobal Regulatory

Mentioned as "next generation lawyer"

Legal 500 EMEA (2017&2018)

Ruth Franken provides practical and hands-on advice regarding the EU and Dutch Life Sciences industry (medicinal products, medical devices and food). She has extensive experience in advising pharmaceutical companies on EU and Dutch regulatory matters, e.g. how to obtain market access through marketing authorization procedures (general requirements, clinical trials, regulatory data protection and exclusivity rights, etc.), pricing and reimbursement (procedures, financial arrangements), commercialization and distribution and how to be compliant in a fast moving and changing environment (interactions with healthcare professionals, compliance issues, audits, legal procedures, etc.). 

Ruth regularly publishes newsletters on European and Dutch Life Sciences developments and contributes to a number of international Life Sciences publications, e.g. the Oxford Handbook on 'Drafting agreements in the biotechnology and pharmaceutical industries', Chambers legal practice guide Life Sciences the Commercialization of Healthcare and Getting the deal through. Ruth is a board member of the Dutch Pharma and Law Association.

Awards and recognitions


Industry Focus: Healthcare and Life Sciences, Next Generation
Legal 500 EMEA


Life Sciences regulatory
Who's Who Legal

Education and admissions


Master of Laws, Radboud University Nijmegen, 2006


Dutch Association for Pharmacy and Law

Dutch Food Law Association

Board member of the Dutch Pharma and Law Association

Representative experience

Advising various national and international pharmaceutical companies in respect of reimbursement and additional financing for expensive medicinal products.

Advising on setting up EU and global compliance policies for pharmaceutical companies.

Advising on reimbursement policies and strategies of Dutch healthcare insurance companies for both medicinal products as well as medical devices.

Advising on the requirements for named patient and compassionate use programs in the Netherlands and other EU member states.

Advising an various issues regarding distribution, import and export of medicinal products.

Ruth contributed to the Oxford Handbook on 'Drafting agreements in the biotechnology and pharmaceutical industries' regarding Dutch law aspects.

Ruth was seconded for over a year on a part time basis to an international pharmaceutical company as legal counsel.

Loading data